Community Cancer Centers
"The Sleeping Giant"

WHY ENGAGE COMMUNITY CANCER CENTERS IN CLINICAL TRIALS

Community Cancer Centers care for more than 80% of Cancer Patients in the U.S. but currently enroll 2% of patients on clinical trials.
So much potential!

Community Cancer Centers are close to home, which minimizes the difficulty and expense of patient travel & allows patients the ability to have more family and friend support during consultations and treatments.
Ease of care, one-stop, personal touch!

Community Cancer Centers don't have the suffocating bureaucracy seen at larger hospitals and academic institutions, which prolongs the trial's study start-up and expense.
Trials can open to accrual in weeks, not months!

TOP 10 REASONS WHY COMMUNITY CANCER CENTERS STRUGGLE WITH RESEARCH

XCANCER A COMPREHENSIVE & PROVEN DIFFERENCE = SUCCESS!

XCANCER provides an experienced and friendly backbone, whether your center is new to research or already has an established clinical trials program that wants a boost.

XCANCER provides strategies, concepts & processes, which all come from the proven successes of a well-established leader in oncology drug development. At the same time, the commonly encountered pitfalls are known and can be avoided at your center. 

XCANCER COMPREHENSIVE SERVICES & OPERATIONAL EXPERTISE

THE BUILDING OF A RESEARCH PROGRAM

A common story that all to often ends in failure!
A decision is made to start a cancer research program. Often an already employed nurse with minimal to no research experience is chosen to run the program and serve as a research coordinator, regulatory expert, and data entry manager. The current administrator may take the budget and contract negotiations duties and blindly track payments without a CTMS. Hopefully, they understand billing issues with research such as determining which visits should be billed to insurance vs. study to avoid legal issues with "double billing".

The physicians rely heavily on this team to identify studies. The physicians are often unaware that their ability to obtain a study depends on their experience and their CRO "Research Score." Higher scores mean a better chance of obtaining better studies. Once a trial has been identified, the program undergoes Site Qualification Visit (SQV), where the sponsor/CRO comes onsite to evaluate your operation and processes.

If a program is chosen as a study site, then they will begin contract and budget negotiations. The administrator or assigned research nurse is often unaware of the potential to secure higher patient budgets for their services. They may also not understand the nuances of sponsor contracts and fail to provide appropriate physicians and practice indemnification. The research staff must also understand and submit/file all regulatory documents to meet Federal compliance and IRB submissions.

After the above negotiations and documents have been completed, the Sponsor/CRO conducts a Site Initiation Visit (SIV). The site is then able to enroll patients. All too often, the study selected doesn't match the patient population, and accrual is slow to non-existent. This hurts the PI research score for future trials. In addition, any revenue generated from an accrued patient may take 3-6 months to arrive.

Even if this is successful and the program grows, unfortunately, there is a need for additional staff/overhead to support. For a majority of sites, the excessive overhead to run a qualified program outpaces the study revenue. The group physicians feel the strain of excessive work, time, and responsibility for the minimal to no ROI. 

XCANCER changes this outcome with a comprehensive team which provides experience & expertise while growing for you so your overhead doesn't!

SURVIVAL OF COMMUNITY CANCER CENTERS

Many U.S. Community Cancer Centers are Struggling Financially.

A strong well run clinical trials program can provide a financial safety net minimizing reliance on declining reimbursements.

XCancer Contact Form

Required information for Clinical Trial or Network Site Consideration.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

XCancer

Office Phone

402-991-8468

Office Fax

Luke Nordquist, MD, FACP
CEO, XCancer

Urology Cancer Center &
GU Research Network, LLC

Luke Nordquist, MD, FACP

Office Phone

402-991-8468

Office Fax

Privacy Policy